Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor-Reference-Cited by-同舟云学术

Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor

Published:2018-08 Issue: Volume:104 Page:686-698
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Feng Kun,Liu Yu,Xu Li-Juan,Zhao Ling-Fei,Jia Chao-Wen,Xu Ming-Yan

Funder

Natural Science Foundation of Heilongjiang Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference30 articles.

1. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer;Xing;JAMA,2013

2. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours;Sheu;Br. J. Cancer,2010

3. MicroRNA expression profiles in papillary thyroid carcinoma, benign thyroid nodules and healthy controls;Yoruker;J. Cancer,2016

4. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years;Hughes;Thyroid,2011

5. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma;Yip;Ann. Surg. Oncol.,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. lncRNA PVT1 silencing inhibits gastric cancer cells’ progression via enhancing chemosensitivity to paclitaxel;Gene;2025-01

2. Insulin-Like Growth Factor 1: A Promoter of Proliferation and Metastasis in Papillary Thyroid Carcinoma Cells;Science of Advanced Materials;2023-06-01

3. Retraction notice to "Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor" [Biomed. Pharmacother. 104 (2018) 686–698];Biomedicine & Pharmacotherapy;2023-06

4. In silico analysis to identify novel ceRNA regulatory axes associated with gallbladder cancer;Frontiers in Genetics;2023-02-16

5. IncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway;Critical Reviews in Eukaryotic Gene Expression;2023